tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Actinogen Medical Highlights Alzheimer’s Trial Progress at 2025 Bioshares Summit

Story Highlights
Actinogen Medical Highlights Alzheimer’s Trial Progress at 2025 Bioshares Summit

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Actinogen Medical ( (AU:ACW) ) has shared an update.

Actinogen Medical announced that its CEO, Dr. Steven Gourlay, will present at the 2025 Bioshares Biotech Summit, discussing the company’s late-stage Alzheimer’s trial and commercialization program. The presentation will cover the progress and potential of Xanamem, a promising therapy for Alzheimer’s and Depression, highlighting the company’s confidence in trial outcomes and interest from potential partners. The ongoing XanaMIA Phase 2b/3 trial and the upcoming XanaMIA-DUR extension trial are key components of Actinogen’s strategy to establish Xanamem as a significant player in the treatment of Alzheimer’s disease, with initial results expected in 2026.

More about Actinogen Medical

Actinogen Medical is an ASX-listed biotechnology company focused on developing novel therapies for neurological and neuropsychiatric diseases linked to dysregulated brain cortisol. Their lead compound, Xanamem, is being developed as a treatment for Alzheimer’s Disease and Depression, with potential applications for Fragile X Syndrome and other conditions. The company aims to address the substantial unmet medical need for improved treatments in these areas.

Average Trading Volume: 7,478,149

Technical Sentiment Signal: Sell

Current Market Cap: A$76.25M

Find detailed analytics on ACW stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1